Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2000
12/07/2000CA2373635A1 Method of producing submicron particles of a labile agent
12/06/2000EP1058117A1 Use of SLIM3 to bind to molecules
12/06/2000EP1057480A2 Transdermal estrogen agonist-antagonist therapy
12/06/2000EP1056774A1 N-terminally truncated glp-1 derivatives
12/06/2000EP1056769A1 15-methyl-cyclopropanosteroids and method for the production thereof
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders
12/06/2000CN1059097C Channel tropism powder
12/06/2000CN1059093C Thyroid gland pill and producing process thereof
12/05/2000US6156786 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
12/05/2000US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
12/05/2000US6156773 Pharmaceutical composition
12/05/2000US6156726 Voltage-gated calcium channel antagonist and method
12/05/2000US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders
12/05/2000US6156523 Serine/threonine protein kinases
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000071736A1 Isoflavonoid methylation enzyme
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000043408A3 Steroid sulfatase inhibitors and methods for making and using the same
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000021572A3 Hydrogels and water soluble polymeric carriers for drug delivery
11/30/2000WO2000021511A3 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/29/2000EP1054676A1 Combination preparation of estrogen and anti-estrogen
11/29/2000CN1275132A Treatmet of obesity
11/29/2000CN1275082A Solid oral dosage form comprising combination of metformin and glibenclamide
11/29/2000CN1058899C Menalgia plaster
11/28/2000US6153768 Benzopyran derivatives
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000CA2309375A1 Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for steroid
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069868A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069442A1 Methods of making and using n-desmethylzopiclone
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO1999061398A3 24-hydroxyvitamin d, analogs and uses thereof
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2505617A1 Modified secretin and method of synthesizing thereof
11/23/2000CA2499211A1 Modified peptides yy and conjugates thereof
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000CA2372068A1 Sulphostin analogue and process for producing sulphostin and its analogue
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1052980A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273966A Process for preparing adrenin beta-excitomotors by combinaion and disconnection method
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150384 Pharmaceutical composition
11/21/2000US6150383 Comprising an insulin sensitivity enhancer in combination with one or more other antidiabetics differing from the enhancer in mechanism of action; lipid/glycometabolism disorders; antidiabetic agents; side effect reduction
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000067785A2 Staphyloccocus aureus antigen-containing whole cell vaccine
11/16/2000WO2000067779A2 Polymerized liposomes for the delivery of mammalian growth hormone
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000027846A3 Crf receptor antagonists and methods relating thereto
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000020358A3 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051193A1 Anhydrous topical skin preparations
11/15/2000EP1051178A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
11/15/2000CN1273121A Process for preparing medicine to cure amenorrhoea
11/15/2000CN1058499C 16-substituted-4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/15/2000CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity
11/14/2000US6147224 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/14/2000US6147119 Biphenyl compounds and use thereof as oestrogenic agents
11/14/2000US6147088 Antagonists of gonadotropin releasing hormone
11/14/2000US6146633 Endogenous and exogenous proteins, and fragments are chemically modified outside the body of an animal so that when injected into the animal, they produce more antibodies against the unmodified protein unmodified protein alone
11/14/2000US6146630 Inhibitors for the adhesion of lymphocytes to glandular cells
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066629A1 Modified exendins and exendin agonists
11/09/2000WO2000066612A1 Androgen glycosides and androgenic activity thereof
11/09/2000WO2000066590A2 Tetracyclic progesterone receptor modulator compounds and methods
11/09/2000WO2000066581A1 Cyanopyrroles as progesterone receptor agonists
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066564A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 290